Cargando…
The effect of semelil (angipars®) on bone resorption and bone formation markers in type 2 diabetic patients
BACKGROUND AND PURPOSE OF THE STUDY: Diabetes mellitus has been recognized as a major risk factor for osteoporosis in which bone turnover is affected by different mechanisms. As the morbidity, mortality and financial cost related to osteoporosis are expected to rise in Iran in coming years, and cons...
Autores principales: | Hasani-Ranjbar, Shirin, Jouyandeh, Zahra, Qorbani, Mostafa, Hemmatabadi, Mahbubeh, Larijani, Bagher |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3556013/ https://www.ncbi.nlm.nih.gov/pubmed/23351359 http://dx.doi.org/10.1186/2008-2231-20-84 |
Ejemplares similares
-
Effects of Semelil (ANGIPARS™) on diabetic peripheral neuropathy: A randomized, double-blind Placebo-controlled clinical trial
por: Bakhshayeshi, S., et al.
Publicado: (2011) -
Effects of Semelil (ANGIPARS™) on focal cerebral ischemia in male rats
por: Asadi-Shekaari, M, et al.
Publicado: (2010) -
Modulatory effect of semelil (ANGIPARS™) on isoproterenol induced cardiac injury
por: Joukar, Siyavash, et al.
Publicado: (2013) -
Prevalence of obesity and overweight in adults and children in Iran; a systematic review
por: Jafari-Adli, Shahrzad, et al.
Publicado: (2014) -
Effect of Semelil, an Herbal Selenium-Based Medicine, on New Bone Formation in Calvarium of Rabbits
por: Rasouli-Ghahroudi, Amir Alireza, et al.
Publicado: (2018)